NEWS
2024 Best Negative Data Prize in Preclinical Neuroscience
April 5, 2024The Global Preclinical Data Forum, in collaboration with Cohen Veterans Bioscience, the Partnership for Assessment and Accreditation of Scientific Practice (PAASP)…
Read More“Aligned on Quality” meeting (Berlin, Oct 10th 2022)
November 2, 2022EQIPD and PAASP, together with colleagues from the QUEST Center and the Global Preclinical Data Forum, led a discussion on how…
Read MoreEQIPD-PAASP working relationship
June 16, 2022As an important step forward in the evolution of the EQIPD quality system for preclinical research, the Guarantors of EQIPD e.V and the PAASP…
Read MoreWebinar at scientist.com
June 21, 2021PAASP network member Christoph Emmerich will introduce the EQIPD framework in the context of scientist.com. Scientist.com is a stakeholder of EQIPD…
Read MoreGreat distinction for PAASP partner Martin C. Michel
December 18, 2020Martin – once again – made it into the Clarivate List of Highly Cited Researchers 2020. This list recognizes true pioneers in…
Read MoreThe BioRN annual conference
December 18, 2020The BIOtech network Rhein-Neckar (BioRN) held its annual (digitally) conference virtually on November 20th. The network brings together a mix of…
Read MoreNew publication co-authored by PAASP: Survey of Core Facilities shows the importance of communication and management for optimal research quality
December 18, 2020PAASP and the Interdisciplinary Neurobehavioral Core (INBC) at the University of Heidelberg aim to establish a quality framework for Core Facilities…
Read MorePAASP publication in Nature Reviews Drug Discovery: Improving target assessment in biomedical research – the GOT-IT recommendations
December 18, 2020The PAASP team has published an article in Nature Reviews Drug Discovery, together with research groups from the Fraunhofer IME-TMP and the…
Read MoreGuidelines for target validation published
November 16, 2020The GOT-IT team, consisting of researchers from the Fraunhofer Institute, Charité and PAASP, announces the publication of their guidelines for target validation…
Read MorePAASP Editorial in the Journal Temperature
October 8, 2020Please following this LINK to our Editorial “Enhancing quality in preclinical data: Of hot science and cool quality”, which was just published in…
Read MoreEQIPD: PAASP’s contribution to the new Quality System for preclinical research
October 8, 2020EQIPD (European Quality In Preclinical Data) is a project that was funded by the Innovative Medicine Initiative with the vision to enable a…
Read MorePEERS – the Platform for the Exchange of Experimental Research Standards
October 8, 2020We are happy to announce that PAASP is part of the PEERS (Platform for the Exchange of Experimental Research Standards) initiative, which is supported by…
Read MoreResearch rigor in preclinical studies on biological effects of whole-body exposure to electromagnetic fields (2G/3G cell phone technology)
May 26, 2020Various modern technologies are known to bear risks to the human health. In many cases, the society learns about these risks…
Read MoreData analysis – Issues, challenges and solutions
March 31, 2020The first official meeting of the Preclinical Data Forum took place in Berlin in 2014 and one of the central seminars was given…
Read MoreNew Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology
February 1, 2020To improve the robustness and transparency of scientific reporting, the American Society for Pharmacology and Experimental Therapeutics (ASPET), with input from PAASP’s Martin…
Read MorePAASP US, LLC receives funding from NIH
January 29, 2020The PAASP Network is very glad to announce that the NIH has awarded an SBIR grant to a Network member –…
Read MorePAASP at the REWARD/EQUATOR Conference in Berlin (February 20-22, 2020)
December 18, 2019We will present our activities to improve Good Research Practice and Data Quality and are very much looking forward to meet…
Read MorePAASP signed the DORA Declaration
December 11, 2019The Declaration on Research Assessment (DORA) recognizes the need to improve the ways in which the outputs of scholarly research are…
Read MoreNews from NIDA
November 22, 2019The National Institute on Drug Abuse (NIDA), part of the US National Institutes of Health (NIH), is pleased to announce an…
Read MorePresentation of the newly developed Guidelines On Target Validation for Innovative Therapeutics (GOT-IT)
November 22, 2019Representing the GOT-IT Team, Christoph Emmerich presented the GOT-IT Guidelines at the “BMBF Vernetzungstreffen zur Nationalen Wirkstoffinitiative” on the 8th of October…
Read MorePAASP US: Poster presentation at the Milken Institute
November 21, 2019The Milken Institute Future of Health Summit (Oct 28-30, 2019) was recently held in Washington D.C. (USA) and brought together thought leaders and…
Read MoreNew members of the PAASP Advisory Board
May 22, 2019We are delighted to announce that Dr. Rita Balice-Gordon and Dr. Phil Skolnick have joined PAASP’s Advisory Board:Rita Balice-Gordon, Ph.D., is…
Read MoreThank you, Bruce! Welcome, Glenn!
March 11, 2019As many of our readers already know, our dear colleague and advisor, Bruce Altevogt, moved on to take a new and…
Read MoreThe US team has won the 6th NIH/NIDA Challenge Award
March 11, 2019In December 2018, the National Institute on Drug Abuse (NIDA) initiated its sixth annual Challenge competition with the aim to solicit…
Read MorePAASP moves across the Atlantic!
March 11, 2019We have always enjoyed our connections to peers in the US and the support from our US-based advisors, but have felt…
Read MorePAASP moves into new offices
December 20, 2018In January 2019, we are moving into new office space, located in the centre of Heidelberg (Kunsthaus 25, Hauptstraße 25, 69117…
Read MorePAASP’s ‘Data Quality’ workshop at HBIGS
November 17, 2018PAASP’s ‘Data Quality’ workshop at the Heidelberg Biosciences International Graduate School (HBIGS) Recognizing the lack of educational courses for students, postdocs…
Read MorePAASP enters a new partnership with HENRICH Pharma-R&D Consulting
July 20, 2018We are proud to announce that PAASP has partnered with HENRICH Pharma-R&D Consulting, a specialised consulting firm located in the Frankfurt…
Read MorePAASP’s ‘Data Quality’ workshop at the Justus-Liebig-University Gießen
February 27, 2018PAASP Partner Prof. Martin Michel led a two-day workshop at the Giessen Graduate Centre for the Life Sciences (GGL). Together with…
Read MorePAASP is part of the BMBF-funded GOT-IT (‘Guidelines On Target Validation for Innovative Therapeutics’) Project
January 23, 2018Medical progress and continued supply of innovative medicines can only be guaranteed by continuous research and development of new active drugs…
Read MoreIMI Call9: PAASP is part of the EQIPD consortium and co-leads the work package responsible for developing a new quality management system to improve preclinical data robustness
December 19, 2017A consortium of pharma companies, SMEs and academic researchers launched an ambitious project to address research quality as one of the…
Read MoreThe new ZWM program now contains a module about Good Research Practice
September 19, 2017PAASP will collaborate with the ZWM (Zentrum für Wissenschaftsmanagement e.V.) to develop and present a course „Werkzeugkoffer für die Professur“ (‚Toolbox for Professors‘),…
Read MoreMeeting Report – St. Petersburg:
June 7, 2017June 1, 2016 – Anton Bespalov participated in the meeting “Current issues in the preclinical and clinical research on novel drugs,…
Read MoreIntroducing StuDySign, an innovative Electronic Lab Notebook (eLN) for biomedical research
May 19, 2017Solid experimental design, data analysis and data storage are among the fundamental requirements for Good Research Practice. Originally, these aspects were…
Read MorePAASP partner became TÜV-certified ‘Qualitätsbeauftragter, -manager and -auditor’
May 7, 2017PAASP partner Björn Gerlach undertook a three-month course focusing on classical quality management systems, like ISO9001 and EFQM. After passing written…
Read MoreBuilding Blocks of Good Research Practice, Amsterdam 2016
December 23, 2016On October 27, 2016, several PAASP team members participated in a meeting in Amsterdam organized by the ECNP Preclinical Data Forum‘s core…
Read MoreLack of reproducibility – an opportunity for precision medicine?
December 23, 2016Our article ‘Reproducibility of Preclinical Data: One Man’s Poison Is Another Man’s Meat’ was published recently by the newly established journal…
Read MoreRe-evaluation of failed drugs and targets using contemporary knowledge, methodology and tools
July 22, 2016Co-authored by PAASP’s managing partner, Anton Bespalov, the correspondence article ‘Failed trials for central nervous system disorders do not necessarily invalidate…
Read MoreBuilding a nearshoring collaboration: Success story
May 30, 2016Starting to work together with someone you do not know is often associated with some risk-taking if this person is outside…
Read MorePAASP enters a new partnership with Arlenda
May 22, 2016Various aspects of the service provided by PAASP are directly or indirectly related to data analysis. While the PAASP team has…
Read MoreY47 Partnership
April 22, 2016PAASP services aim to identify areas that need improvement and to provide our clients with the necessary tools. We believe that…
Read MoreDGGF Membership
March 20, 2016DGGF MembershipPAASP became a member of the DGGF (Deutsche Gesellschaft für Gute Forschungspraxis; German Society for Good Research Practice).The DGGF is the largest…
Read MoreThe Wheel of Science
February 20, 2016You might have seen the Wheel of Science (WoS) on the front page of our website – but what does it actually mean…
Read MorePAASP: current and future activities
February 20, 2016PAASP was founded with the mission to ‘protect the integrity of science, increase reproducibility and ensure proper training of new generations…
Read MoreIntroducing PAASP: Why not a non-profit organisation?
February 20, 2016We, Anton Bespalov, Björn Gerlach and Christoph Emmerich, the three co-founders of PAASP, all reside in Germany and we have carefully…
Read More